CD55 Antikörper
(2 Referenzen)Kurzübersicht für CD55 Antikörper (ABIN2480961)
Target
Alle CD55 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Produktmerkmale
- Purified IgG
-
Aufreinigung
- Purified
-
Immunogen
- Human fibroblast cell line
-
Isotyp
- IgG1
-
-
anti-Complement Decay-Accelerating Factor (CD55) (AA 35-134) antibody
CD55 Reaktivität: Human WB, ELISA, PLA Wirt: Maus Monoclonal 1G3 unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (AA 35-285) antibodyCD55 Reaktivität: Human WB, ELISA, IHC (fro), ICC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (AA 40-300) antibodyCD55 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (AA 51-79) antibodyCD55 Reaktivität: Human WB, FACS, IHC, IF, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (Center) antibodyCD55 Reaktivität: Human WB, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (AA 35-134) antibodyCD55 Reaktivität: Human WB, IF, ELISA Wirt: Maus Monoclonal 1D7 unconjugated
anti-Complement Decay-Accelerating Factor (CD55) antibodyCD55 Reaktivität: Human, Non-Human Primate WB, FACS, IP, IHC (p) Wirt: Maus Monoclonal MEM-118 unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (AA 254-372) antibodyCD55 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (AA 35-126) antibodyCD55 Reaktivität: Human IHC, IF, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Decay-Accelerating Factor (CD55) antibody (Biotin)CD55 Reaktivität: Human, Non-Human Primate WB, FACS, IP, IHC (p) Wirt: Maus Monoclonal MEM-118 Biotin
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1.0 mg/mL
-
-
-
: "Inhibition of decay-accelerating factor (CD55) attenuates prostate cancer growth and survival in vivo." in: Neoplasia (New York, N.Y.), Vol. 8, Issue 1, pp. 69-78, (2006) (PubMed).
: "Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome." in: Molecular immunology, Vol. 44, Issue 7, pp. 1559-68, (2006) (PubMed).
-
: "Inhibition of decay-accelerating factor (CD55) attenuates prostate cancer growth and survival in vivo." in: Neoplasia (New York, N.Y.), Vol. 8, Issue 1, pp. 69-78, (2006) (PubMed).
-
- CD55 (Complement Decay-Accelerating Factor (CD55))
-
Andere Bezeichnung
- CD55
-
Hintergrund
- Synonyms: DAF
-
Gen-ID
- 1604
-
UniProt
- P08174
-
Pathways
- Komplementsystem, Regulation of Leukocyte Mediated Immunity
Target
-
